VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its ...
BioNxt Solutions (OTCQB:BNXTF) has executed an agreement to carry out comparative drug absorption study for its transdermal (TDS) Rotigotine patch for the treatment of Parkinson's disease. The company ...
XPhyto has outlined plans to move its rotigotine transdermal patch into a pivotal clinical trial. The Canadian company committed to further development of the rival to UCB’s Neupro after completing a ...
A study supported by the Alzheimer's Drug Discovery Foundation and published today in JAMA Network Open provides the first evidence that rotigotine, a drug that acts on dopamine transmission in the ...
May 31 -- FRIDAY, May 30 (HealthDay News) -- Skin patches that contain the drug rotigotine help relieve restless legs syndrome (RLS), according to a German study. Dopaminergic drugs -- which stimulate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback